Eight Biotech Growth Names: Greg Wade
The Life Sciences Report: Greg, you are coming off of a pretty good year. Congratulations on that. I realize that 2012 was a good year in general for biotech. What was that about? Greg . . . → Read More: Eight Biotech Growth Names: Greg Wade Similar posts: Analyst Bets on Extraordinary Science and Clinical Data: Greg Wade The Life Sciences Report: The Wedbush Management Conference was held... Why M&A Flurry Has Top MKM Analyst Smiling All the Way to the Bank The Life Sciences Report: Since the end of November, biotech,... Special Report Reveals Biotech Stock Drivers: Michael Hay The Life Sciences Report: From a share price perspective, what’s...
The Life Sciences Report: Greg, you are coming off of a pretty good year. Congratulations on that. I realize that 2012 was a good year in general for biotech. What was that about?
Greg Wade: It was about the healthy financing we saw throughout the year, which was facilitated by a couple of factors. A widespread decline in volatility globally in the marketplace was notable. Low volatility creates healthy financing environments. Risk capital was seeking an environment where growth could be generated against a backdrop of global economic uncertainty. That made healthcare an … [visit site to read more]
- Analyst Bets on Extraordinary Science and Clinical Data: Greg Wade The Life Sciences Report: The Wedbush Management Conference was held...
- Why M&A Flurry Has Top MKM Analyst Smiling All the Way to the Bank The Life Sciences Report: Since the end of November, biotech,...
- Special Report Reveals Biotech Stock Drivers: Michael Hay The Life Sciences Report: From a share price perspective, what’s...